Therapeutic Drug Monitoring for Individualized Antidepressant Treatment
Drug Design, Development and Therapy · 2025-12 · Volume 19 · 11585-11608
DOI: 10.2147/dddt.s566716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-12. Verfasst von Yumeng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Hebei Medical University, Shijiazhuang, Hebei, 050017, People's Republic of China. Hauptthemen laut MEDLINE: Antidepressive Agents, Drug Monitoring, Precision Medicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Hebei Medical University, Shijiazhuang, Hebei, 050017, People's Republic of China.
- Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, 050051, People's Republic of China.
ORCID-Profile: Huizhen Wu
Zitieren
APA
Li, Y., Du, X., An, J., & Wu, H. (2025). Therapeutic Drug Monitoring for Individualized Antidepressant Treatment. Drug Design, Development and Therapy, Volume 19, 11585-11608. https://doi.org/10.2147/dddt.s566716
Vancouver
Li Y, Du X, An J, Wu H. Therapeutic Drug Monitoring for Individualized Antidepressant Treatment. Drug Design, Development and Therapy. 2025;Volume 19:11585-11608. doi:10.2147/dddt.s566716
BibTeX
@article{Li2025,
author = {Li, Yumeng and Du, Xiaoyu and An, Jing and Wu, Huizhen},
title = {Therapeutic Drug Monitoring for Individualized Antidepressant Treatment},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {11585--11608},
doi = {10.2147/dddt.s566716}
}
EUVIMED